Apolipoprotein C3, triglycerides, and cardiovascular risk in optimally treated ACS patients: The critical role of mediation analysis and implications for precision primary prevention: Reply.
Schwartz GG, Szarek M, Steg PG. Apolipoprotein C3, triglycerides, and cardiovascular risk in optimally treated ACS patients: The critical role of mediation analysis and implications for precision primary prevention: Reply. Eur J Prev Cardiol. 2025 Mar 10.